Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
World’s First Whole-Eye and Face Transplant Breakthrough
In a groundbreaking medical feat, a surgical team comprising more than 140 clinicians, including surgeons, nurses, and various healthcare professionals from New York University (NYU) Langone Health, has successfully conducted the world’s first whole-eye and partial face transplantation on a…
AMD Forecast: New Algorithm Offers 94% Accuracy
Researchers at Duke University have developed a computer program that can predict with 94% accuracy whether an individual’s age-related macular degeneration (AMD) will deteriorate within a year. The deep learning algorithm, featured in an article within JAMA Ophthalmology, evaluates comprehensive…
Blind Canvas Project by Ora and BlindCAN Film Festival
Ora and the BlindCAN Film Festival have jointly unveiled The Blind Canvas Project, an initiative that leverages the capabilities of storytelling and generative artificial intelligence (AI) to cultivate a more profound comprehension of the lives and narratives of individuals affected…
Pantheon Receives $2.5M Funding for Corneal Implant
Pantheon Vision has secured $2.5 million in seed financing from KeraLink International (KLI), a Baltimore-based non-profit organization dedicated to eliminating corneal blindness, with a specific focus on low- and middle-income countries. This funding will launch the development bioengineered corneal implant.…
Ocular Therapeutix Gets FDA Agreement for Wet AMD Trial
Ocular Therapeutix has obtained written FDA approval for the comprehensive design of its pivotal phase 3 clinical trial, known as the SOL trial, which evaluates Axpaxli (axitinib intravitreal implant) for treating wet age-related macular degeneration (AMD) under a Special Protocol…
Seeing Beyond: Community and Inclusion in Ophthalmology – Emory School of Medicine
Seeing Beyond: Community and Inclusion in Ophthalmology Emory School of Medicine Source: Author: | Date: 2023-11-01 13:42:00 Source: Author: | Date: 2023-11-01 13:42:00
FDA Greenlights Phase 1 Trial for IOPCL Magnifier
OnPoint Vision has officially received FDA approval for their investigational device exemption (IDE) application, initiating the phase 1 in the pivotal clinical trial for the AccuraSee Intraocular Pseudophakic Capsular Lens (IOPCL) Magnifier (MAG). This trial focuses on the secondary implantation…
Opthea Announces Key Leadership Changes for 2025 Launch
Opthea has announced key leadership appointments to strengthen its commercial and clinical capabilities as it prepares for the 2025 topline data readout of Phase 3 trials for sozinibercept, its lead candidate for wet AMD. New Leadership Appointments • Daniel Geffken –…
What Is Idiopathic Multifocal Choroiditis and How to Manage It|OBN
What Is Idiopathic Multifocal Choroiditis? Idiopathic Multifocal Choroiditis (IMFC) is a rare eye condition that primarily affects the choroid, a vascular layer situated between the retina and the sclera (the white part of the eye). The condition is characterized by…
Haag-Streit Launches of New Office in Japan
Haag-Streit has announced the launch of Haag-Streit Japan KK, strengthening its regional presence after recent expansions into China and Singapore. “Our expansion into Japan is a milestone in Haag-Streit’s international commercial expansion plan,” Dr. Stefan Haag, CMO of Haag-Streit Group…